Sublingual Ketamine: An Option for Increasing Accessibility of Ketamine Treatments for Depression?
Clicks: 148
ID: 114201
2020
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
In this letter to the editor, Drs Swainson and Khullar describe their experiences with use of sublingual ketamine in the clinical setting and argue that it may be an accessible alternative for appropriate patients.| Reference Key |
swainson2020thesublingual
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jennifer Swainson;Atul Khullar; |
| Journal | the journal of clinical psychiatry |
| Year | 2020 |
| DOI | DOI not found |
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.